Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Squamous Cell of the Head and Neck”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00002533
What this trial is testing

Fluconazole in Preventing Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer

Who this might be right for
Head and Neck CancerInfectionOral Complications
University of Miami
Testing effectiveness (Phase 2)Study completedNCT00005599
What this trial is testing

Bryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer or Stomach Cancer

Who this might be right for
Esophageal CancerGastric Cancer
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Ended earlyNCT03906526
What this trial is testing

Evaluate Immune Biomarker Modulation in Response to VTX-2337 in Combination With an Anti- PD-1 Inhibitor in Head and Neck Cancer

Who this might be right for
Carcinoma, Squamous Cell
Celgene 15
Testing effectiveness (Phase 2)Study completedNCT00020189
What this trial is testing

Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck CancerThromboembolism
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT02508389
What this trial is testing

The Effects of GC4419 on Radiation Induced Oral Mucositis in Patients With Head/Neck Cancer

Who this might be right for
Radiation Induced Oral Mucositis
Galera Therapeutics, Inc. 223
Large-scale testing (Phase 3)WithdrawnNCT04129320
What this trial is testing

Enoblituzumab Plus MGA012 or MGD013 in Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck CancerSquamous Cell Carcinoma of Head and Neck
MacroGenics
Testing effectiveness (Phase 2)Ended earlyNCT00573989
What this trial is testing

Intensity-Modulated Radiation Therapy, Pemetrexed, and Erlotinib in Treating Patients With Recurrent or Second Primary Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Wake Forest University Health Sciences 27
Testing effectiveness (Phase 2)Study completedNCT03633110
What this trial is testing

Safety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted Vaccine

Who this might be right for
Cutaneous MelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma of the Head and Neck+2 more
Genocea Biosciences, Inc. 24
Very early researchStudy completedNCT00696176
What this trial is testing

STAT3 DECOY in Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
University of Pittsburgh 32
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)WithdrawnNCT01674374
What this trial is testing

Botanical Therapy in Treating Mucositis in Patients With Head and Neck Cancer Who Have Undergone Chemoradiation Therapy

Who this might be right for
MucositisRecurrent Squamous Cell Carcinoma of the HypopharynxRecurrent Squamous Cell Carcinoma of the Larynx+29 more
Roswell Park Cancer Institute
Not applicableStudy completedNCT02372890
What this trial is testing

Validation of High-resolution PET/CT for the Pretherapeutic Lymphnode Staging of Head/Neck Cancer

Who this might be right for
Otorhinolaryngeal NeoplasmsCancer of Head and Neck
Insel Gruppe AG, University Hospital Bern 153
Not applicableLooking for participantsNCT07794813
What this trial is testing

Trop2-targeting NIR-II Molecular Probe for Precision Diagnosis of Oral Cancer

Who this might be right for
Oral Squamous Cell Carcinoma (OSCC)Diagnosis
Yunnan Cancer Hospital 40
Testing effectiveness (Phase 2)WithdrawnNCT01465815
What this trial is testing

Phase I/II Study of Postoperative Adjuvant Chemoradiation for Advanced-Stage Cutaneous Squamous Cell Carcinoma of the Head and Neck (cSCCHN)

Who this might be right for
Recurrent Skin CancerRecurrent Squamous Cell Carcinoma of the Lip and Oral CavitySquamous Cell Carcinoma of the Skin+3 more
OHSU Knight Cancer Institute
Early research (Phase 1)Study completedNCT00036790
What this trial is testing

Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersColorectal Cancer+9 more
University of Wisconsin, Madison
Testing effectiveness (Phase 2)Study completedNCT00255476
What this trial is testing

The IRESSA Novel Head and Neck Chemotherapy Evaluation Study

Who this might be right for
Squamous Cell CancerCancer of Head and Neck
AstraZeneca 64
Testing effectiveness (Phase 2)Looking for participantsNCT06354218
What this trial is testing

Serplulimab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old Age

Who this might be right for
Esophageal Carcinoma
The First Affiliated Hospital with Nanjing Medical University 50
Testing effectiveness (Phase 2)Looking for participantsNCT05025813
What this trial is testing

Neoadjuvant Pembrolizumab in Cutaneous Squamous Cell Carcinoma

Who this might be right for
Cutaneous Squamous Cell Carcinoma of the Head and NeckHead and Neck Cancer
Queensland Health 27
Testing effectiveness (Phase 2)UnknownNCT00003257
What this trial is testing

Gene Therapy in Treating Patients With Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Aventis Pharmaceuticals 39
Testing effectiveness (Phase 2)Study completedNCT01588431
What this trial is testing

Bevacizumab/Ph 2 for Locally Advanced Head and Neck Cancer

Who this might be right for
Carcinoma, Squamous Cell of Head and Neck
The University of Texas Health Science Center at San Antonio 3
Next Page